男女羞羞视频在线观看,国产精品黄色免费,麻豆91在线视频,美女被羞羞免费软件下载,国产的一级片,亚洲熟色妇,天天操夜夜摸,一区二区三区在线电影
Global EditionASIA 中文雙語Fran?ais
World
Home / World / China-US

Virus collaborations rise despite tensions

By LIA ZHU in San Francisco | China Daily Global | Updated: 2020-08-27 11:27
Share
Share - WeChat
A scientist at RNA medicines company Arcturus Therapeutics research a vaccine for the novel coronavirus (COVID-19) at a laboratory in San Diego, California, US, March 17, 2020. [Photo/Agencies]

Scientists in the US and China, the world's top two producers of scientific research, are collaborating more on COVID-19 research despite mounting political tensions, a series of studies have found.

"We were quite surprised by our results. ... Our findings indicate that the two nations are conducting the most COVID-19 research, and they're continuing to collaborate more with each other than with any other countries," said Jenny Lee, a professor at the Center for the Study of Higher Education at the University of Arizona, during a recent webinar.

"The rate of collaboration increased significantly — 5 percent — over the rate of collaboration prior to the pandemic. It's also higher than the rate of collaboration on non-COVID-19 research," she said.

Lee, along with John Haupt, a doctoral candidate at the center, conducted studies on US-China scientific collaboration through bibliometric methods. Their latest study, published last month by Higher Education: The International Journal of Higher Education Research, examined the patterns and nature of science co-publications between the US and China over the past five years.

Challenging US political rhetoric and attempts to curb international research engagement with China, their findings show that China plays a leading role in US-China research collaboration, based on first authorship and governmental funding patterns.

While members of the US government and many lawmakers accuse China and its nationals of stealing intellectual property from the US, the research found the opposite: China is actually leading in US-China co-authored studies, said Lee.

She said the studies also debunked the so-called China threat, as the findings showed that over the past five years, US research article publications would have declined without Chinese co-authorship, whereas China's publication rate would have risen without the US.

While US publications have remained relatively steady, China's rise has been about twice as fast as the world's average. Just a few years ago, China surpassed the US in the top position in science publications, according to Lee.

"The US needs China more than China needs the US when we look at the rate of scientific publications," she said.

The US and China dominate the global scientific system by being the two largest producers of scientific knowledge and two largest research collaborators in the world; when combined, the two countries account for over half of the world's scientific articles over the past decade, according to Lee.

Using zero-sum and positive-sum frameworks, Lee and Haupt's study demonstrates US collaboration with China benefits both the US and global science, especially at a time of global health crisis.

But Lee warned that the Trump administration's "barriers" are challenging the global science system.

Prior to the novel coronavirus pandemic, the US has already proposed numerous policies to decrease scientific engagement, especially with China, including denying visas for Chinese students and researchers, banning Chinese funding sources and developing protocols to monitor Chinese scholars in the US, said Lee.

"Numerous prominent organizations have warned that such a sweeping approach would harm the overall scientific enterprise," she said.

According to a 2018 survey by the Union of Concerned Scientists, more than 63,000 scientists in 16 federal agencies reported interference from government officials, with 50 percent indicating that political interests hinder the ability of their agencies to make science-based decisions.

In handling the COVID-19 crisis, the Trump administration ordered all hospitals to bypass the US Centers for Disease Control and Prevention (CDC) and submit all coronavirus data to a different federal agency, said Lee, adding that an earlier survey of CDC scientists found the greatest barrier to science-based decisions was the White House.

The challenges have included reports of scientific studies being halted, edited or suppressed, the sidelining of scientific advice, and political oversight over grant reviews, she said.

"For example, a major NIH (National Institutes of Health)-funded study on how the coronavirus moves from bats to humans was suddenly defunded without clear evidence of wrongdoing," said Lee. "Scientific experts expressed concern because this study countered conservative US political and media claims that the virus escaped from a laboratory in China."

The White House has strategically aligned the COVID-19 threat with the previous "China threat" narrative — labeling the coronavirus a "Chinese virus", placing the blame squarely on China, she said.

Most Viewed in 24 Hours
Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
主站蜘蛛池模板: 沿河| 宁城县| 定边县| 积石山| 阿坝县| 观塘区| 诏安县| 湟中县| 柯坪县| 通河县| 罗定市| 治多县| 双桥区| 洞口县| 清新县| 蒲城县| 怀远县| 蒙山县| 满城县| 泰州市| 思南县| 达日县| 吉木萨尔县| 兴宁市| 张家川| 观塘区| 禄丰县| 平安县| 子洲县| 澄江县| 宜黄县| 临清市| 深州市| 奇台县| 永兴县| 姜堰市| 德钦县| 吉林省| 大渡口区| 深泽县| 汉寿县| 平武县| 西藏| 沛县| 平湖市| 平泉县| 磴口县| 安图县| 雷州市| 牟定县| 崇州市| 巨野县| 虹口区| 石楼县| 兴文县| 巴彦淖尔市| 于都县| 温州市| 灌阳县| 康平县| 大荔县| 抚顺市| 杭州市| 贺州市| 淳化县| 肥乡县| 大埔区| 涞源县| 绥化市| 确山县| 乐清市| 中宁县| 韶关市| 驻马店市| 陈巴尔虎旗| 瓦房店市| 德惠市| 遵义县| 大同县| 三门峡市| 巴楚县| 买车|